Biomarker Breakthrough Could Improve Parkinson’s Treatment
University of FloridaA new, non-invasive way to track the progression of Parkinson’s disease could help evaluate experimental treatments to slow or stop the disease’s progression.
A new, non-invasive way to track the progression of Parkinson’s disease could help evaluate experimental treatments to slow or stop the disease’s progression.
MINNEAPOLIS – Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the August 10, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
There is growing evidence that sleep disorders like insomnia and sleep apnea are related to stroke risk and recovery from stroke, according to a recent literature review. The review is published in the August 3, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
MINNEAPOLIS – An updated recommendation from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart. The practice advisory, which updates a previous AAN guideline, is published in the July 27, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Contrary to popular belief, taking estrogen after menopause may not affect the memory and thinking abilities of healthy women no matter when the treatment is started. The research is published in the July 20, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A gene associated with Alzheimer’s disease and recovery after brain injury may show its effects on the brain and thinking skills as early as childhood, according to a study published in the July 13, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
New research finds white matter changes in the brains of athletes six months after a concussion. The study will be presented at the Sports Concussion Conference in Chicago, July 8-10, hosted by the American Academy of Neurology, the world’s leading authority on the diagnosis and management of sports-related concussion. The conference brings together leading experts in the field to present and discuss the latest scientific advances in diagnosing and treating sports-related concussion.
MINNEAPOLIS – New research shows that a genetic risk score may detect those at higher risk for Alzheimer’s disease long before symptoms appear—even possibly in healthy young adults, according to a study published in the July 6, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A phase II clinical trial in people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, suggests that transplanting human stem cells into the spinal cord may be done safely. The research is published in the June 29, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. While the study was not designed to determine whether the treatment was effective, researchers noted that it did not slow down the progression of the disease.
In a proof-of-principle study, a team of physicians and bioinformatics experts at Johns Hopkins reports they were able to diagnose or rule out suspected brain infections using so called next-generation genetic sequencing of brain tissue samples.
Having a first-degree relative with epilepsy may increase a person’s risk of being diagnosed with autism, according to a study published in the June 15, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new drug to prevent migraine was associated with fewer headache hours for people with chronic migraine within three to seven days after the first injection, according to a study published in the June 8, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Chronic migraine is defined as headaches occurring at least 15 days per month. Study participants had migraine attacks for an average of 20 years prior to treatment.
Researchers have long known that sex hormones such as estrogen play a role in migraine. But there’s been little research on how that works. Do women with migraine have higher estrogen levels in general? Higher levels at the peak of the monthly cycle?
Researchers have identified a group of immune system genes that may play a role in how long people can live after developing a common type of brain cancer called glioblastoma multiforme, a tumor of the glial cells in the brain. The research is published in the May 25, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The multiple sclerosis (MS) drug mitoxantrone may be associated with an increased risk of colorectal cancer, according to a study published in the May 11, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. Mitoxantrone suppresses the immune system. It was first developed as a chemotherapy drug for certain cancers.
Families rely on doctor recommendations after a brain hemorrhage, but new research shows different physicians make very different decisions.
People who have had a traumatic brain injury (TBI) may still have sleep problems a year and a half after being injured, according to a study published in the April 27, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. In addition, people with TBI may also be unaware of just how much their sleep is disturbed.
Resistance, stability and flexibility training can improve balance and other functional movements for people diagnosed with multiple sclerosis—and behavior therapy may further improve their quality of life. That’s the premise of a study that builds on previous work suggesting that resistance and flexibility training improved balance and symmetry, which is of particular concern for those experiencing leg weakness.
Athletes who have medical complaints, like aches and pains, that have no known physical cause may take longer to recover after a concussion, according to a study published in the April 20, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Athletes who have medical complaints, like aches and pains, that have no known physical cause may take longer to recover after a concussion, according to a study published in the April 20, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
New research suggests that looking at structures in the right side of the brain may help predict who will better recover from language problems after a stroke, according to a study published in Neurology®, a medical journal of the American Academy of Neurology.
Exercise in older people is associated with a slower rate of decline in thinking skills that occurs with aging. People who reported light to no exercise experienced a decline equal to 10 more years of aging as compared to people who reported moderate to intense exercise, according to a population-based observational study published in the March 23, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
People newly diagnosed with multiple sclerosis (MS) may often have other chronic health conditions as well, according to a study published in the March 9, 2016 online issue of Neurology®, the medical journal of the American Academy of Neurology.
Young adults with hostile attitudes or those who don’t cope well with stress may be at increased risk for experiencing memory and thinking problems decades later, according to a study published in the March 2, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
A new discovery about ischemic stroke may allow to doctors to predict a patient’s risk of having a second stroke using a commonly performed blood test and their genetic profile.
People who keep mentally and physically healthy in middle age may help stave off the symptoms of Alzheimer’s disease, but the activity does not affect the underlying disease changes in the brain for most people, according to a study published in the February 24 online edition of Neurology®, the medical journal of the American Academy of Neurology.
Keeping the mind active may delay symptoms of Alzheimer’s disease; however, the activity does not change the underlying disease in the brain for most people, according to a study published today in the online edition of Neurology.
Antibiotics may be linked to a serious disruption in brain function, called delirium, and other brain problems, more than previously thought, according to a “Views and Reviews” article published in the February 17, 2016, online issue of Neurology®, a medical journal of the American Academy of Neurology.
A new study suggests that people with brain injuries following head trauma may have buildup of the plaques related to Alzheimer’s disease in their brains. The research is published in the February 3, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Older people with higher amounts of a key protein in their brains also had slower decline in their memory and thinking abilities than people with lower amounts of protein from the gene called brain-derived neurotrophic factor, or BDNF, according to a study published in the January 27, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.
People who take the drug natalizumab for multiple sclerosis may have up to a 10 times greater risk of developing a risk biomarker for activity of a virus that can lead to an often fatal brain disease, according to a study published in the January 27, 2016, online issue of Neurology® Neuroimmunology and Neuroinflammation, a medical journal of the American Academy of Neurology.
Research shows blacks are nearly three times more likely to have a stroke at age 45 than whites.
Even though young African-Americans are at three times greater risk of a first stroke than their white counterparts, they may not be at a higher risk for a second stroke, according to a study published in the January 20, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first of its kind to look at race and second stroke risk.